FRUSCIO, ROBERT
FRUSCIO, ROBERT
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
High-performance liquid chromatography/tandem mass spectrometry for the quantitative analysis of a novel taxane derivative (BAY59-8862) in biological samples and characterisation of its metabolic profile in rat bile samples
2001 Sottani, C; Colombo, T; Zucchetti, M; Fruscio, R; D'Incalci, M; Minoia, C
Preclinical activity and biodistribution of Ecteinascidin 743 (ET-743) and Doxorubicin (DOX) combinations in human rhabdomyosarcoma
2001 R, I; Meco, D; Riccardi, A; Mazzarella, G; Ubezio, P; Colombo, T; Zucchetti, M; Frapolli, R; Fruscio, R; Zaffaroni, M; Giavazzi, R; Faircloth, G; Jimeno, J
High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma
2002 Zaffaroni, M; Frapolli, R; Colombo, T; Fruscio, R; Bombardelli, E; Morazzoni, P; Riva, A; D'Incalci, M; Zucchetti, M
Unique features of the mode of action of ET-743
2002 D'Incalci, M; Erba, E; Damia, G; Galliera, E; Carrassa, L; Marchini, S; Mantovani, R; Tognon, G; Fruscio, R; Jimeno, J; Faircloth, G
Ifosfamide in the treatment of malignant epithelial ovarian tumors
2003 Lissoni, A; Fei, F; Rossi, R; Fruscio, R; Villa, A; Zani, G
PRL-3 phosphatase is implicated in ovarian cancer growth
2005 Polato, F; Codegoni, A; Fruscio, R; Perego, P; Mangioni, C; Saha, S; Bardelli, A; Broggini, M
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients
2006 Fruscio, R; Lissoni, A; Frapolli, R; Corso, S; Mangioni, C; D'Incalci, M; Zucchetti, M
Flow cytometric DNA content analysis in 708 patients affected by ovarian cancer. Clinical correlations
2006 Garbi, A; Signorelli, M; Dell'Anna, T; Fruscio, R; Torri, V; Clivio, L; Mangioni, C; D'Incalci, M; Erba, E
Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery
2007 Assi, F; Fruscio, R; Bonardi, C; Ghidini, A; Allavena, P; Mantovani, A; Locatelli, A
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer
2007 Vecchione, F; Fruscio, R; Dell'Anna, T; Garbi, A; Garcia Parra, R; Corso, S; Lissoni, A
Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer
2008 Pellegrino, A; Fruscio, R; Maneo, A; Corso, S; Battistello, M; Chiappa, V; Stomati, M
Synchronous early-stage endometrial and ovarian cancer
2008 Signorelli, M; Fruscio, R; Lissoni, A; Pirovano, C; Perego, P; Mangioni, C
DeltaNp63 expression is associated with poor survival in ovarian cancer
2008 Marchini, S; Marabese, M; Marrazzo, E; Mariani, P; Cattaneo, D; Fossati, R; Compagnoni, A; Fruscio, R; Lissoni, A; Broggini, M
Analysis of gene expression in early-stage ovarian cancer
2008 Marchini, S; Mariani, P; Chiorino, G; Marrazzo, E; Bonomi, R; Fruscio, R; Clivio, L; Garbi, A; Torri, V; Cinquini, M; Dell'Anna, T; Apolone, G; Broggini, M; D'Incalci, M
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis
2008 Fruscio, R; Colombo, N; Lissoni, A; Garbi, A; Fossati, R; Ieda', N; Torri, V; Mangioni, C
Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer
2008 Pellegrino, A; Villa, A; Fruscio, R; Signorelli, M; Meroni, M; Iedà, N; Vitobello, D
Malignant transformation of vaginal endometriosis treated with neoadjuvant chemotherapy and surgery
2008 Fruscio, R; Padula, F; Mancini, E; Pellegrino, A; De Nictolis, M
Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma
2009 Signorelli, M; Chiappa, V; Minig, L; Fruscio, R; Perego, P; Caspani, G; Battistello, M; Colombo, N
Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: Analysis of surgical and oncological outcome
2009 Pellegrino, A; Vizza, E; Fruscio, R; Villa, A; Corrado, G; Villa, M; Dell'Anna, T; Vitobello, D
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors
2009 Kieran, M; Supko, J; Wallace, D; Fruscio, R; Poussaint, T; Phillips, P; Pollack, I; Packer, R; Boyett, J; Blaney, S; Banerjee, A; Geyer, R; Friedman, H; Goldman, S; Kun, L; Macdonald, T